Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)

Ji Hyun Park, Sang Hoon Chun, Yun Gyoo Lee, Hyun Chang, Keun Wook Lee, Hye Ryun Kim, Seong Hoon Shin, Ho Jung An, Kyoung Eun Lee, In Gyu Hwang, Myung Ju Ahn, Sung Bae Kim, Bhumsuk Keam

Research output: Contribution to journalComment/debate

Abstract

In the original article published, the first name of the author is incorrect. The correct author name is Ji Hyun Park.

Original languageEnglish
Pages (from-to)3371
Number of pages1
JournalJournal of Cancer Research and Clinical Oncology
Volume146
Issue number12
DOIs
StatePublished - Dec 2020

Bibliographical note

Publisher Copyright:
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.

Fingerprint

Dive into the research topics of 'Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)'. Together they form a unique fingerprint.

Cite this